en
Scientific article
Open access
English

Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors

Published inJournal of acquired immune deficiency syndromes, vol. 57, no. 1, p. 24-31
Publication date2011
Abstract

Nucleoside reverse transcriptase inhibitors (NRTIs) are often administered in salvage therapy even if genotypic resistance tests (GRTs) indicate high-level resistance, but little is known about the benefit of these additional NRTIs.

Keywords
  • Adult
  • Anti-HIV Agents/administration & dosage
  • Cohort Studies
  • Female
  • HIV Infections/blood/drug therapy/virology
  • HIV-1/growth & development
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Pyrrolidinones/administration & dosage
  • RNA, Viral/blood
  • Reverse Transcriptase Inhibitors/administration & dosage
  • Salvage Therapy/methods
Citation (ISO format)
SCHERRER, Alexandra U et al. Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. In: Journal of acquired immune deficiency syndromes, 2011, vol. 57, n° 1, p. 24–31. doi: 10.1097/QAI.0b013e318211925e
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1525-4135
617views
1570downloads

Technical informations

Creation10/25/2012 1:02:00 PM
First validation10/25/2012 1:02:00 PM
Update time03/14/2023 7:55:44 PM
Status update03/14/2023 7:55:44 PM
Last indexation01/16/2024 12:52:08 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack